Summary Breast cancer prognosis has previously been linked to the degree of tumour vascularisation. In order to establish additional markers for tumour angiogenesis, we have used monoclonal antibodies against the endothelial Tie receptor tyrosine kinase to study the degree of vascularisation of breast carcinomas and the regulation of Tie expression in the vascular endothelial cells. Antibodies were used for Tie detection and the results were correlated with other prognostic markers. Of four monoclonal antibodies directed against different epitopes of the Tie extracellular domain, two reacted against Tie in unfixed histopathological sections of breast carcinomas. One of these antibodies (clone 7e8) was specific for the endothelial cells whereas the other (clone 10fl 1) also reacted with basement membranes and occasional carcinoma cells. When Tie expression was studied with the antibody clone 7e8, all 27 carcinomas, two in situ carcinomas, samples of histologically normal breast tissue (n = 16) or normal skin or lymph node tissue (n= 5) showed staining. Microvessel counts were higher in carcinomas (median 14; range 3 -27) than in fibrodenomas (median 10; range 5 -18) or histologically normal breast tissue (median 7; range 3 -15, P = 0.0006). A similar result was obtained using antibodies against the CD31 (PECAM) antigen. Microvessel counts in 7e8 staining were not significantly associated with primary tumour size, axillary nodal status, histological grade or staining for oestrogen receptor, progesterone receptor, Ki-67 proliferation marker or p53 oncoprotein.
Receptor tyrosine kinases (RTKs) play key roles in signal transduction across the plasma membrane and thus have a significant role in regulating cellular proliferation and differentiation (van der Geer et al., 1994) . Tie and Tek (Dumont et al., 1993) are members of a new subfamily of endothelial cell RTKs whose extracellular domains contain three different types of structural motifs: immunoglobulin (Ig)-like loops, cysteine-rich epidermal growth factor (EGF)-like domains and fibronectin type III (FN III) domains (Maisonpierre et al., 1993; Sato et al., 1993; Ziegler et al., 1993) .
The pattern of Tie mRNA distribution in embryonic endothelia and also in some tumours suggests that Tie plays an important role in the development of embryonic vasculature and possibly also in angiogenesis associated with tumorigenesis. Tie mRNA is especially prominent in endothelial cells during embryonic angiogenesis (Sato, et al., 1993; Dumont, et al., 1993; Korhonen et al., 1992 Korhonen et al., , 1994 Korhonen et al., , 1995 . Disruption of the Tie gene locus by targeted mutagenesis was lethal. Tie-deficient embryos survived after the time point when Tie expression normally begins, but the mice died of haemorrhage soon after birth (Puri et al., 1995; Sato et al., 1995) . Analysis of these pups indicates that Tie is essential for the formation of microvessels and that this defect is cell-autonomous (Puri et al., 1995) . Thus, one could speculate that the inhibition of Tie function could have therapeutic potential in the prevention of proliferation of the microvascular endothelium in human solid tumours.
In adult mice, Tie mRNA has been detected in vascular endothelium of capillaries of the lung, kidney and bone marrow (Korhonen, et al., 1994) . Tie mRNA has also been detected in endothelia of various tissues of adult rats. (Maisonpierre, et al., 1993) . These tissues include brain, cerebellum, heart, skeletal muscle, lung, kidney, liver, spleen, thyroid, adrenal gland and ovary. However, the signal for Tie mRNA is reduced in the endothelia of neural tissues of adult rats when compared with the embryonic and neonatal neural tissue. Expression of Tie mRNA has also been detected in human haematopoietic progenitor cells (Batard et al., 1996; Hashiyama et al., 1996) , in leukaemia cell lines and in some cell lines from solid tumours Armstrong et al., 1993) . Several studies have pointed out the importance of angiogenesis for tumour growth and progression (Folkman, 1990 (Folkman, , 1992 . Microvessel density has been shown to be an independent parameter of the severity of tumour disease and a predictor of prognosis of breast cancer patients in most but not all studies addressing this issue (Weidner et al., 1991 (Weidner et al., , 1992 Bosari et al., 1992; Horak et al., 1992; Toi et al., 1993 , Axelsson et al., 1995 . A similar correlation has also been demonstrated with other human malignancies, including head and neck squamous cell carcinoma (Gasparini et al., 1993) , lung adenocarcinoma (Yamazaki et al., 1994) , rectal carcinoma (Saclarides et al., 1994) , testicular germ cell tumours (Olivarez et al., 1994) , prostate cancer , tumours of the oral cavity (Williams et al., 1994) and gastric carcinoma (Maeda et al., 1995 rie receptor in breast cancer P Salven et al higher when staining was performed using the clone 7E8 antibody (Table I) . No specific staining was observed when the sections were incubated with antigen-blocked antibody instead of the primary antibodies, or with the peroxidaseconjugated secondary antibody only.
Tie protein in breast tumours Microvessel counts in fibroadenomas were not significantly higher than those found in normal breast when the anti-Tie antibody clone 7e8 was used (median, 10 per hpf vs 7 respectively, P=0.12). The microvessel counts were higher in fibroadenomas than in histologically normal breast tissue when anti-CD31 staining was used (median, 21 vs 15 respectively, P=0.02). Tie expression was also detected in vessels around intraductal cancer and lobular carcinoma in situ with the anti-Tie antibody clone 7e8. Tie protein was detected in the endothelial cells of microvessels in all breast carcinoma samples studied with the clone 7e8 antibody ( Figure Ic) . The number of stained microvessels was greater in breast carcinomas than in normal breast tissue when staining was performed with the clone 7e8 antibody (median, 14 vs 7 respectively, P= 0.0002). The highest microvessel counts were also clearly greater in breast cancer tissue than in normal breast tissue in staining for CD31 (median, 30 vs 15 respectively, P<0.0001). No specific staining was observed when the tumour sections were incubated with antigen-blocked antibody or normal serum instead of the anti-Tie antibodies ( Figure Id) .
In some of the invasive breast carcinoma samples the antiTie antibody clone 10fl 1 also stained carcinoma cells, basement membranes and myoepithelial cells, whereas the clone 7e8 antibody stained vascular endothelial cells only.
The highest microvessel counts obtained by staining for Tie protein with the two anti-Tie antibodies and for CD31 were correlated with the primary tumour size (<2 cm vs >2 cm), presence of axillary nodal metastases (pNO vs pN +), histological gradus (well-or moderately differentiated vs poorly differentiated), oestrogen and progesterone receptor status, Ki-67 expression (lower vs higher than the median, 15%), and p53 expression (negative vs positive) among the 27 carcinomas studied, but no significant correlations were found between these parameters and the microvessel counts.
Discussion
Several studies have suggested that the Tie protein plays an important role in angiogenesis Sato et al., 1993; Korhonen et al., 1994 Korhonen et al., , 1995 . In recent studies high amounts of Tie mRNA and also Tie protein have been detected in human brain tumours in contrast to the less abundant expression of Tie mRNA or protein in the respective normal brain tissue control samples (Kaipainen et al., 1994; Hatva et al., 1995) . These studies suggest that a significant difference exists in the expression of Tie when the endothelia of malignant tumours of the CNS are compared with the endothelia of normal adult brain.
71
Our results show Tie protein in the vascular endothelia of several types of normal human tissues, including normal skin and breast tissue. In a previously published work with human melanoma and normal skin samples using in situ hybridisation the Tie probe hybridised very weakly with the vascular endothelium of capillaries of normal skin, except for the endothelium of sweat gland vessels (Kaipainen et al., 1994) . In addition, Tie expression appeared to be enhanced in areas of inflammatory reaction around certain skin melanomas. The differences between the results in this in situ hybridisation and the present immunohistochemical staining results can be due to a tissue-specific variation in the level of Tie expression, a difference in the sensitivity of detection techniques used or translational regulation of Tie expression. The fact that the 10flf antibody cross-reacts with an antigen expressed in ductal myoepithelium and some breast carcinomas is not unexpected among monoclonal antibodies, which often detect very small epitopes. Such epitopes may resemble structures in other proteins. However, at least in brain tumours and melanomas Tie sequences as such are only expressed in tumour endothelia and not detected in in situ hybridisation of the tumour cells (Hatva, et al., 1995; Kaipainen, et al., 1994) Tumour angiogenesis is essential for tumour growth and metastasis and intratumoral microvessel density correlates with prognosis in breast carcinoma and also in other human tumours. In this study the difference in the Tie-positive microvessel counts between the groups of invasive breast carcinomas and normal breast tissue samples was statistically significant (Mann-Whitney test, P=0.0002). The difference between these groups was similar to the difference observed when using the anti-CD31 antibody. This result suggests that Tie might have significance as an indicator of tumour angiogenesis and as a prognostic marker for breast cancer patients. Although the microcapillary network of breast carcinomas is known to be unevenly distributed, our results do not suggest that Tie would be up-regulated in breast carcinomas. Whether Tie is enhanced in tumour vessels outside the central nervous system needs further study using more quantitative methods of analysis. Thus we cannot yet exclude scenarios of tumour treatment based on possible differential Tie expression in normal and tumour endothelia. However, the Tie receptor may appear on the luminal surface of endothelial cells and circulating Tie antigen may be present in the blood. Such findings could preclude the use of anti-Tie antibodies for intravascular injection because of the possible 
